{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/heart-failure-chronic/management/end-stage-heart-failure/","result":{"pageContext":{"chapter":{"id":"28fde475-ef24-59d3-9171-a8d59a3fb149","slug":"end-stage-heart-failure","fullItemName":"Scenario: End-stage heart failure","depth":2,"htmlHeader":"<!-- begin field fd3f0976-1fec-4ec9-bd60-fce3edb83c06 --><h2>Scenario: End-stage heart failure</h2><!-- end field fd3f0976-1fec-4ec9-bd60-fce3edb83c06 -->","summary":"Covers the management of people with end-stage heart failure, including advanced care planning and symptom management.","htmlStringContent":"<!-- begin item 4f3f98a0-85a7-4097-a63e-8a5a5f8db58d --><!-- begin field 5f0d2100-d236-41fa-b394-acd900ad56f5 --><p>From age 16 years onwards.</p><!-- end field 5f0d2100-d236-41fa-b394-acd900ad56f5 --><!-- end item 4f3f98a0-85a7-4097-a63e-8a5a5f8db58d -->","topic":{"id":"3a35207f-30ea-5eca-bfcf-dff091a73359","topicId":"fdc42e20-2c4b-45ed-9093-6c2d4bde6e4d","topicName":"Heart failure - chronic","slug":"heart-failure-chronic","lastRevised":"Last revised in January 2017","chapters":[{"id":"77c928c1-46d0-58c1-ba79-6015f89bc48a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"f0aa9151-9d10-566e-85ec-6ccefed25f20","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"c036596d-f29d-5486-822a-b46af76451d7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"fd5e8a95-3e97-5ec2-98ae-5a10c2373213","slug":"changes","fullItemName":"Changes"},{"id":"4c4375f1-a348-5b99-b895-f04a15c64791","slug":"update","fullItemName":"Update"}]},{"id":"7472c037-35d4-5fd2-bba6-dfd891ade816","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"cde936d1-3945-5bc6-8c22-9106d78cf77c","slug":"goals","fullItemName":"Goals"},{"id":"bfa0b8d3-fac0-500e-a762-f719dc619f1b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5d2cf55e-1ae2-5000-9c94-e9c86d26a824","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c8203a8a-fc22-5378-b33b-34ddf818dea5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"4b5e4f72-1a3e-531c-be82-a1919603c934","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"c206f1b2-7616-587d-b3bf-b65ba5b5adb4","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ab1d2b81-1f2b-55e5-abf0-c14e4ae4a78d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"cb83ac3c-e97e-5cab-acca-5abebc7bd6b1","slug":"definition","fullItemName":"Definition"},{"id":"66c995b7-504c-5510-9e77-1a9b27ee7dca","slug":"causes","fullItemName":"Causes"},{"id":"88dbdf7b-53b7-5952-97b9-2312c0a2ce63","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a0b16521-d808-5dfd-89dc-64fc6ae7f6ce","slug":"prognosis","fullItemName":"Prognosis"},{"id":"262fb896-526d-594f-8142-98c291781249","slug":"complications","fullItemName":"Complications"}]},{"id":"72804751-fb0c-5a96-85b5-982feb950f16","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"8b798e41-3fbe-5027-9365-da41e1c98e93","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"e6498250-f313-5ea2-a1e8-2d0342823c39","slug":"how-to-manage-suspected","fullItemName":"How to manage suspected"},{"id":"74e553b4-7cb8-52a6-a573-8715f63a2ba8","slug":"how-to-assess","fullItemName":"How to assess"},{"id":"53bf7ae0-a1d0-5fae-9d3b-57cbc6f03bb8","slug":"what-else-could-it-be","fullItemName":"What else could it be"}]},{"id":"38c5edc8-6b4a-5e71-bb70-cf0a09389ae0","fullItemName":"Management","slug":"management","subChapters":[{"id":"97a0eca4-a290-588b-a16a-bc95b93cd893","slug":"confirmed-heart-failure-with-reduced-ejection-fraction","fullItemName":"Scenario: Confirmed heart failure with reduced ejection fraction"},{"id":"34ff8094-815a-55b7-9edd-49f3ac636471","slug":"confirmed-heart-failure-with-preserved-ejection-fraction","fullItemName":"Scenario: Confirmed heart failure with preserved ejection fraction"},{"id":"28fde475-ef24-59d3-9171-a8d59a3fb149","slug":"end-stage-heart-failure","fullItemName":"Scenario: End-stage heart failure"},{"id":"c587255a-a47e-57a1-bc4d-967753c38d11","slug":"information-advice-follow-up-referral","fullItemName":"Scenario: Information and advice, follow-up, and referral"}]},{"id":"e82d6013-cb43-59d5-9e2e-0af05276fb9d","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8fd96acc-3fa6-528b-9351-49db836228b1","slug":"managing-aiiras","fullItemName":"Managing AIIRAs"},{"id":"06c9d276-e5ea-5a0b-9ff4-343f10034763","slug":"managing-ace-inhibitors","fullItemName":"Managing ACE-inhibitors"},{"id":"df53e9a8-07f8-5d37-94cf-78e99d4c8216","slug":"managing-beta-blockers","fullItemName":"Managing beta-blockers"},{"id":"faad170c-d1ee-59ad-9847-f7afdda6d9b9","slug":"managing-diuretics","fullItemName":"Managing diuretics"},{"id":"a3ea6beb-7ee3-586c-9985-47c20d804195","slug":"covid-19","fullItemName":"COVID-19"}]},{"id":"7b9c5d56-39f1-53df-b1f9-2dcc5bbb498a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"df3b6e0c-ca5a-59eb-93e6-4b4370389ed2","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7a756ff1-7152-5bdd-92ca-7f9e67351dd9","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f5e1707e-f2a9-54e0-92fa-71beb41e38af","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"691681cc-720f-5242-9fb3-3040860027e7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7f39ec24-cb87-5fba-ae6b-6fb2d9538859","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4afe2b30-f837-53a3-88df-7b1913a54081","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d4dace55-ef1c-5675-bdbe-180512d549fa","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"38c5edc8-6b4a-5e71-bb70-cf0a09389ae0","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"093d1ce0-20a9-5c5e-b228-becf183ca086","slug":"when-to-suspect","fullItemName":"When to suspect","depth":3,"htmlHeader":"<!-- begin field e08d93b3-4952-4f22-bfe5-d35141a8a40b --><h3>When should I suspect end-stage heart failure?</h3><!-- end field e08d93b3-4952-4f22-bfe5-d35141a8a40b -->","summary":null,"htmlStringContent":"<!-- begin item acb88d91-ee73-477d-b9c2-39734c5beace --><!-- begin field 207f9e30-da50-4bd9-b445-9e78ede16b3a --><ul><li><strong>People can be regarded as being in end-stage heart failure if they are at high risk of dying within the next 6–12 months.</strong></li><li><strong>Common symptoms in end-stage heart failure include:</strong><ul><li>Pain.</li><li>Breathlessness.</li><li>Persistent cough.</li><li>Fatigue.</li><li>Limitation of physical activity.</li><li>Depression and anxiety.</li><li>Constipation.</li><li>Loss of appetite and nausea.</li><li>Oedema.</li><li>Insomnia.</li><li>Cognitive impairment.</li></ul></li><li><strong>Predicting the illness trajectory can be difficult.</strong> Indicators of people likely to have end-stage heart failure include:<ul><li>Frequent hospital admissions.</li><li>Poor response to treatment and severe breathlessness at rest (New York Heart Association class IV).</li><li>Presence of cardiac cachexia.</li><li>Low serum albumin.</li><li>Progressive deterioration in estimated glomerular filtration rate (eGFR) and hypotension limiting the use of drug treatments.</li><li>Acute deterioration and increasingly frequent hospital admissions from comorbid conditions (such as a chest infection).</li><li>Poor quality of life and dependence on others for most activities of daily living.</li><li>People who are clinically judged to be close to the end of life.</li></ul></li><li>The <a href=\"http://www.goldstandardsframework.org.uk/cd-content/uploads/files/General%20Files/Prognostic%20Indicator%20Guidance%20October%202011.pdf\" data-hyperlink-id=\"a4fc5e42-4789-4be3-be6e-a93100980543\">Prognostic Indicator Guidelines</a> can be used to estimate prognosis. It is part of the Gold Standards Framework, which aims to optimize the care of people nearing the end of life who are looked after by primary care teams.</li><li>For further information, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/management/terminal-phase/#assessing-prognosis\">Assess prognosis</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul><!-- end field 207f9e30-da50-4bd9-b445-9e78ede16b3a --><!-- end item acb88d91-ee73-477d-b9c2-39734c5beace -->","subChapters":[{"id":"f94cd944-c1de-51bb-94e0-20c06e2b0831","slug":"basis-for-recommendation-e44","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e4a6e848-a73e-47f8-a628-9812dadb2b99 --><h4>Basis for recommendation</h4><!-- end field e4a6e848-a73e-47f8-a628-9812dadb2b99 -->","summary":null,"htmlStringContent":"<!-- begin item e44d30d3-2314-426b-9aeb-31a5ed6c192e --><!-- begin field 6af9583c-f974-4132-a931-caa62b769b1b --><h5>When to suspect end-stage heart failure</h5><ul><li>Information about when to suspect end-stage heart failure is based on expert consensus opinion in a regional guideline <em>Symptom control for patients with end-stage heart failure and criteria for referral for specialist palliative care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Gardner et al, 2009</a>].</li></ul><h5>Common symptoms of end-stage heart failure</h5><ul><li>These symptoms are based on expert consensus opinion in a local guideline <em>Symptom control for patients with end-stage heart failure and criteria for referral for specialist palliative care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Gardner et al, 2009</a>], and expert opinion in a position statement from the Heart Failure Association of the European Society of Cardiology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>].</li></ul><h5>Indicators of end-stage heart failure</h5><ul><li>Information that predicting the illness trajectory is difficult is based on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Stewart and McMurray, 2002</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>]. Complex scoring systems exist regarding the prediction of outcome in chronic heart failure [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Pocock et al, 2013</a>], but simple clinical acumen is recommended for the majority of people with severe heart failure in the position statement from the European Society of Cardiology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>].</li><li>Indicators of when to adopt a palliative care approach are based on expert opinion in guidelines published by the Heart Failure Society of America [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Heart Failure Society of America, 2010</a>], the National Institute for Health and Clinical Excellence (NICE) <em>Chronic heart failure in adults, diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">NICE, 2018</a>] the European Society of Cardiology guideline <em>Guidelines for the diagnosis and treatment of acute and chronic heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">European Society of Cardiology, 2012</a>], and the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guideline <em>Guideline for the management of heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Yancy et al, 2013</a>].</li></ul><!-- end field 6af9583c-f974-4132-a931-caa62b769b1b --><!-- end item e44d30d3-2314-426b-9aeb-31a5ed6c192e -->","subChapters":[]}]},{"id":"c4e3e796-9f36-586d-a2c0-6ae9dbf9b94a","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field b6c14611-f4a8-4763-bcf0-c7b4ba28e27c --><h3>How should I manage a person with end-stage heart failure?</h3><!-- end field b6c14611-f4a8-4763-bcf0-c7b4ba28e27c -->","summary":null,"htmlStringContent":"<!-- begin item 0e54dcca-b413-47c9-a409-4afd197c62e2 --><!-- begin field 3eb3c794-e328-46e4-a2d0-d8300450d46c --><ul><li><strong>Liaise with a cardiologist if there is uncertainty about the use of further treatments, and to make sure all treatment options have been considered</strong> (including planned deactivation of implantable cardioverter-defibrillators [ICDs]), if appropriate.<ul><li>Information for professionals regarding emergency temporary deactivation of ICDs is available from the British Heart Foundation (<a href=\"https://www.bhf.org.uk/~/media/files/publications/hcps/icd-deactivation.pdf\" data-hyperlink-id=\"fbbeb488-66a7-4dca-82a8-a931009927c7\">www.bhf.org.uk)</a>. For patient information, see the British Heart Foundation's leaflet on <a href=\"https://www.bhf.org.uk/publications/living-with-a-heart-condition/deactivating-the-shock-function-of-an-implantable-cardioverter-defibrillator-towards-the-end-of-life\" data-hyperlink-id=\"a89a1d89-f29d-420c-b68d-a93100992895\">Deactivating the shock function of an implantable cardioverter defibrillator towards the end of life</a>.</li></ul></li><li><strong>Explore the person's understanding and provide an appropriate explanation of the situation including realistic goals of care with the person and their family/carers.</strong><ul><li>Goals of care should be evaluated repeatedly during disease progression, anticipating that people may frequently want to modify their decisions.</li></ul></li><li><strong>Involve and coordinate care with the multidisciplinary team (MDT)</strong> which may include community nurses, heart failure specialist nurses, a palliative care team, occupational therapists, physiotherapists, dietetics, out-of-hours services, and hospice care.</li><li><strong>Review the need for medication and provide symptom relief:</strong><ul><li><strong>Breathlessness</strong> — optimize standard <a class=\"topic-reference internal-reference\" href=\"/topics/heart-failure-chronic/management/confirmed-heart-failure-with-reduced-ejection-fraction/#management\">treatment</a>. If this is ineffective, consider prescribing an opioid, a benzodiazepine, and/or home oxygen. For information on when and how to prescribe these treatments, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-dyspnoea/\">Palliative care - dyspnoea</a>.</li><li><strong>Pain</strong> — chest pain is often due to cardiac ischaemia, and this can be relieved by prescribing morphine and nitrates. For prescribing information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/angina/\">Angina</a> and <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/\">Palliative cancer care - pain</a>. For the management of generalized pain, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/\">Palliative cancer care - pain</a>.</li><li><strong>Anxiety and depression</strong> — for advice regarding the management of anxiety and depression, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/management/management-approach/#assessing-managing-psychological-needs\">Assessing and managing psychological needs</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>. For prescribing information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>.</li><li><strong>Insomnia</strong> — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/insomnia/\">Insomnia</a>.</li><li><strong>Constipation, nausea, and loss of appetite</strong> — for more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-constipation/\">Palliative care - constipation</a> and <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-nausea-vomiting/\">Palliative care - nausea and vomiting</a>.</li></ul></li><li><strong>Ensure the person has an advance care plan (if they wish).</strong> It should be reviewed regularly and should address:<ul><li>Anticipatory prescribing of medication to manage symptoms and when, who, and how to call for help when there is a crisis or acute exacerbation.</li><li>Needs for psychological and spiritual care.</li><li>Care of the family (before and after the person's death).</li><li>Information on prognosis in a sensitive, open and honest manner.</li><li>The person’s preferences regarding the location in which they wish to be cared for and whether resuscitation should be attempted if they were to have a life-threatening deterioration. This information should be made available to out-of-hours and ambulance services.</li></ul></li><li><strong>Discuss advance decisions</strong> (also called advance directives or living wills) which allow the person to specify (before they have lost capacity to decide) what treatments they would not want and would not consent to.<ul><li>For further information on advance decisions see the section on <a class=\"topic-reference external-reference\" href=\"/topics/dementia/diagnosis/assessment/#consent-capacity\">The Mental Capacity Act 2005</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dementia/\">Dementia</a>.</li></ul></li><li><strong>For information regarding available resources for healthcare professionals caring for people receiving end-of-life care,</strong> see the section on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/management/communication/#help-advice-in-primary-care\">help and advice in primary care</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/palliative-care-general-issues/\">Palliative care - general issues</a>.</li></ul><!-- end field 3eb3c794-e328-46e4-a2d0-d8300450d46c --><!-- end item 0e54dcca-b413-47c9-a409-4afd197c62e2 -->","subChapters":[{"id":"c6d43883-212d-5cd7-ab34-ace56a8558a9","slug":"basis-for-recommendation-f57","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 935338d0-e1ac-4d5b-823b-66938d28afcd --><h4>Basis for recommendation</h4><!-- end field 935338d0-e1ac-4d5b-823b-66938d28afcd -->","summary":null,"htmlStringContent":"<!-- begin item f57fee37-3675-4164-8d3e-9d420e26c7ac --><!-- begin field 9062de47-8f1e-4a07-9e42-e5ec687545ba --><h5>Liaising with cardiology</h5><ul><li>This recommendation is based on information in a position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>], which states that co-ordination of care is needed.</li><li>The recommendation regarding the planned deactivation of devices such as implantable cardioverter-defibrillators (ICDs) is based on information in the position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>], which states that repeated ICD firing in the terminal phase can be very distressing (although people can be reassured that ICD deactivation is not expected to immediately result in the death of the person).</li></ul><h5>Exploring the person's understanding and providing information</h5><ul><li>This recommendation is based on information in the position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>]. The National Institute for Health and Clinical Excellence (NICE) also found substantial evidence from observational studies that people with heart failure and their informal carers have considerable unmet needs, such as symptom control, psychological and social support, planning for the future, and end-of-life care [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">NICE, 2018</a>].</li><li>The recommendation to frequently review goals of care is based on information in the position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>].</li></ul><h5>Co-ordination of care services</h5><ul><li>This recommendation is based on information in the position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>].</li></ul><h5>Reviewing medication and providing symptom relief</h5><ul><li>The recommendation to review the need for medication is based on information in the Scottish Intercollegiate Guidelines Network (SIGN) <em>Management of chronic heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">SIGN, 2016</a>], and a position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>]. It is recommended that decisions to adjust or discontinue drugs should be taken prospectively rather than as a response to adverse effects and to consider the relative merits of treatment for symptomatic relief and those offered primarily to improve prognosis.</li><li>Recommendations regarding symptom management are based on information in the regional guideline <em>Symptom control for patients with end-stage heart failure and criteria for referral for specialist palliative care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Gardner et al, 2009</a>], a position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>], and the SIGN guideline <em>Management of chronic heart failure </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">SIGN, 2016</a>], and the NICE guideline <em>Improving supportive and palliative care for adults with cancer</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">NICE, 2004</a>].</li></ul><h5>Ensuring the person has an advance care plan if they wish</h5><ul><li>These recommendations are based on information from guidelines published by NICE<em> Improving supportive and palliative care for adults with cancer</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">NICE, 2004</a>], and <em>Chronic heart failure in adults: diagnosis and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">NICE, 2018</a>], a position statement from the Heart Failure Association of the European Society of Cardiology <em>Palliative care in heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>], a guideline from SIGN <em>Management of chronic heart failure</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">SIGN, 2016</a>], and a guideline from the General Medical Council <em>Treatment and care towards the end of life: good practice in decision-making</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">GMC, 2010</a>].</li><li>The recommendation that care plans should be reviewed regularly is based on information that the goals of care often change, and cognitive impairment and other comorbidities may necessitate the review of decisions and medications on a regular basis. This is stated in a position statement from the Heart Failure Association of the European Society of Cardiology Palliative care in heart failure [<a class=\"bibliography-reference internal-reference\" href=\"/topics/heart-failure-chronic/references/\">Jaarsma et al, 2009</a>].</li></ul><h5>Discussing advance decisions</h5><ul><li>Information regarding the evidence for discussing advance decisions is in the section on <a class=\"topic-reference external-reference\" href=\"/topics/dementia/diagnosis/assessment/#consent-capacity\">The Mental Capacity Act 2005</a> in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/dementia/\">Dementia</a>.</li></ul><!-- end field 9062de47-8f1e-4a07-9e42-e5ec687545ba --><!-- end item f57fee37-3675-4164-8d3e-9d420e26c7ac -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}